Latus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
Provides AI-powered platforms and integrated services for drug discovery and development
Develops and commercializes rare disease therapies using AI
Pitching 8VC? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room